Medical Cannabis Helped a Heart Patient Whose Pain Didn't Respond to Morphine

A 63-year-old man with inoperable coronary artery disease and unstable angina unresponsive to morphine and standard medications experienced significant pain reduction and improved exercise tolerance after starting medical cannabis.

Shaffer, Brian L et al.·Medicine·2021·Preliminary EvidenceCase Report
RTHC-03516Case ReportPreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

After failing all first- and second-line cardiac medications and morphine for unstable angina, a patient using edible 1:1 CBD:THC medical cannabis reported reduced frequency and severity of angina pain, discontinued long-term morphine, and showed improved functional capacity on exercise tolerance tests.

Key Numbers

63-year-old male; 22-year cardiac history; inoperable triple-vessel CAD; 6 years of progressive unstable angina despite medical management; 1:1 CBD:THC edible; ceased long-term morphine; improved exercise tolerance test results.

How They Did This

Single case report of a 63-year-old male with complex cardiac history and inoperable triple-vessel coronary artery disease treated with edible medical cannabis in conjunction with standard cardiac care.

Why This Research Matters

For patients with refractory angina who have exhausted conventional treatment options, this case raises the possibility that cannabis may offer supplementary pain relief, though controlled studies are needed.

The Bigger Picture

The endocannabinoid system's role in cardiovascular function, including vasodilation and cardioprotection during ischemia, provides a biological rationale for why cannabis might affect cardiac symptoms, but the complex cardiovascular risks of cannabis also warrant caution.

What This Study Doesn't Tell Us

Single case report cannot establish efficacy or safety; placebo effect cannot be ruled out; cannabis carries its own cardiovascular risks; may not generalize to other patients.

Questions This Raises

  • ?Could cannabis reduce morphine requirements in other refractory angina patients?
  • ?What cardiovascular risks might cannabis pose in patients with existing CAD?

Trust & Context

Key Stat:
Patient ceased long-term morphine after starting medical cannabis for refractory angina
Evidence Grade:
Single case report providing preliminary evidence in a patient who had failed standard treatments.
Study Age:
Published in 2021.
Original Title:
Application of medical cannabis in unstable angina and coronary artery disease: A case report.
Published In:
Medicine, 100(11), e25172 (2021)
Database ID:
RTHC-03516

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Frequently Asked Questions

Can cannabis help with heart-related chest pain?

This single case report described improvement in a patient with refractory angina after starting medical cannabis, but case reports cannot prove efficacy. Controlled trials are needed, especially given cannabis's own cardiovascular risks.

What form of cannabis was used?

The patient used an edible form with a 1:1 ratio of CBD to THC, taken in conjunction with his standard cardiac medications.

Read More on RethinkTHC

Cite This Study

RTHC-03516·https://rethinkthc.com/research/RTHC-03516

APA

Shaffer, Brian L; Davis, Garrison M; Incitti, Marc A; Piper, Brian J; Entler, Brian V. (2021). Application of medical cannabis in unstable angina and coronary artery disease: A case report.. Medicine, 100(11), e25172. https://doi.org/10.1097/MD.0000000000025172

MLA

Shaffer, Brian L, et al. "Application of medical cannabis in unstable angina and coronary artery disease: A case report.." Medicine, 2021. https://doi.org/10.1097/MD.0000000000025172

RethinkTHC

RethinkTHC Research Database. "Application of medical cannabis in unstable angina and coron..." RTHC-03516. Retrieved from https://rethinkthc.com/research/shaffer-2021-application-of-medical-cannabis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.